Literature DB >> 11751392

Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.

L Bello1, V Lucini, G Carrabba, C Giussani, M Machluf, M Pluderi, D Nikas, J Zhang, G Tomei, R M Villani, R S Carroll, A Bikfalvi, P M Black.   

Abstract

Angiogenesis, tumor cell proliferation, and migration are the hallmarks of solid tumors, such as gliomas. This study demonstrates that a fragment derived from the autocatalytic digestion of matrix metalloproteinase (MMP)-2, called PEX, acts simultaneously as an inhibitor of glioma angiogenesis, cell proliferation, and migration. PEX is detected in the cultured medium of various human glioma, endothelial, breast, and prostate carcinoma cell lines. PEX is purified from the medium of glioma cell lines by chromatography, where PEX is constitutively expressed as a free and a TIMP-2-bound form. In human glioma tissue, PEX expression correlates with histological subtype and grade and with alpha v beta 3 integrin expression to which it is bound. Systemic administration of PEX to s.c. and intracranial human glioma xenografts results in a 99% suppression of tumor growth with no signs of toxicity. Thus, PEX is a very promising candidate for the treatment of human malignant gliomas.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11751392

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

Review 1.  Stem cells as therapeutic vehicles for the treatment of high-grade gliomas.

Authors:  Emanuela Binello; Isabelle M Germano
Journal:  Neuro Oncol       Date:  2011-12-13       Impact factor: 12.300

2.  Effects of thalidomide on parameters involved in angiogenesis: an in vitro study.

Authors:  M Gelati; E Corsini; S Frigerio; B Pollo; G Broggi; D Croci; A Silvani; A Boiardi; A Salmaggi
Journal:  J Neurooncol       Date:  2003-09       Impact factor: 4.130

Review 3.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

Review 4.  Human nerual stem cells for brain repair.

Authors:  Seung U Kim; Hong J Lee; In H Park; Kon Chu; Soon T Lee; Manho Kim; Jae K Roh; Seung K Kim; Kyu C Wang
Journal:  Int J Stem Cells       Date:  2008-11       Impact factor: 2.500

5.  Angiogenesis and the growth potential of craniopharyngiomas.

Authors:  Sergio Vidal; Bernd W Scheithauer; Kalman Kovacs; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 6.  Engineering Stem Cells for Biomedical Applications.

Authors:  Perry T Yin; Edward Han; Ki-Bum Lee
Journal:  Adv Healthc Mater       Date:  2015-03-13       Impact factor: 9.933

7.  Volume reconstruction techniques improve the correlation between histological and in vivo tumor volume measurements in mouse models of human gliomas.

Authors:  Karl F Schmidt; Mateo Ziu; Nils Ole Schmidt; Pramil Vaghasia; Theresa G Cargioli; Sameer Doshi; Mitchell S Albert; Peter McL Black; Rona S Carroll; Yanping Sun
Journal:  J Neurooncol       Date:  2004-07       Impact factor: 4.130

Review 8.  Applications of neural and mesenchymal stem cells in the treatment of gliomas.

Authors:  Thomas Kosztowski; Hasan A Zaidi; Alfredo Quiñones-Hinojosa
Journal:  Expert Rev Anticancer Ther       Date:  2009-05       Impact factor: 4.512

9.  Nano to micro delivery systems: targeting angiogenesis in brain tumors.

Authors:  Ariel Gilert; Marcelle Machluf
Journal:  J Angiogenes Res       Date:  2010-10-08

10.  Front instabilities and invasiveness of simulated 3D avascular tumors.

Authors:  Nikodem J Poplawski; Abbas Shirinifard; Ubirajara Agero; J Scott Gens; Maciej Swat; James A Glazier
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.